COVID-19 Trial of the Candidate Vaccine MVA-SARS-2-S in Adults
Stopped Results from Phase 1 lead to the decision
Conditions
Interventions
- BIOLOGICAL: MVA-SARS-2-S
- OTHER: Placebo
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]